Motilal Oswal Alternates has raised over Rs 1,750 crore for its sixth real estate fund to invest in top eight cities of India ...

Motilal Oswal lists Sun Pharma, Mankind Pharma, Max Healthcare,, and Ipca Labs as its top picks in the sector.

Brokerage firm Motilal Oswal has recommended three stocks - Mahindra and Mahindra, Kalyan Jewellers and Policy Bazaar - to ...

Index mutual funds are mutual fund schemes that track the performances of specific market indices. Index mutual funds, ...

Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter, ...

The company's revenue is likely to grow by 6.3 per cent Y-o-Y on an average to Rs 6,445.63 crore as compared to Rs 6,060 ...

According to analysts, key metrics such as the total contract value (TCV) of deal wins, hiring trends, offshoring ratios, and ...

The Standard Glass Lining Technology IPO received 27,75,52,115 bids against offered 2,08,29,567 equity shares. The issue was ...

However, in the first half of FY25, the government's capex fell by 13.5 per cent year-on-year (YoY), reaching only 39.1 per cent of the budget estimate. This is lower than the 50 per cent achieved in ...

Infosys Q3FY25 results forecast: analysts predict guidance revision, revenue growth, EBIT margin, deal wins, and headcount ...

The initial public offering of Standard Glass Lining enters Day 2 on a strong note with a subscription of 13.32 times. The ...

Motilal Oswal recommended a 'buy' call on the stock and raised the target price to Rs 3,850. This implies an upside potential of 11 percent from the last closing price of Rs 3,470 on the NSE.